These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1711654)

  • 21. The distribution of substance P in the cerebral cortex and hippocampal formation: an immunohistochemical study in the monkey and rat.
    Iritani S; Fujii M; Satoh K
    Brain Res Bull; 1989 Feb; 22(2):295-303. PubMed ID: 2468400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromogranin A-like immunoreactive neurites are major constituents of senile plaques.
    Munoz DG
    Lab Invest; 1991 Jun; 64(6):826-32. PubMed ID: 1710735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
    Beal MF; Mazurek MF
    Neurology; 1987 Jul; 37(7):1205-9. PubMed ID: 2439949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease.
    Hof PR; Nimchinsky EA; Celio MR; Bouras C; Morrison JH
    Neurosci Lett; 1993 Apr; 152(1-2):145-8. PubMed ID: 8515868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.
    Chan-Palay V; Lang W; Allen YS; Haesler U; Polak JM
    J Comp Neurol; 1985 Aug; 238(4):390-400. PubMed ID: 2413088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin-releasing factor immunoreactive neurons persist throughout the brain in Alzheimer's disease.
    Kelley M; Kowall N
    Brain Res; 1989 Nov; 501(2):392-6. PubMed ID: 2819447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease.
    Hof PR; Cox K; Young WG; Celio MR; Rogers J; Morrison JH
    J Neuropathol Exp Neurol; 1991 Jul; 50(4):451-62. PubMed ID: 2061713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease.
    Terai K; Matsuo A; McGeer PL
    Brain Res; 1996 Sep; 735(1):159-68. PubMed ID: 8905182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer's disease.
    Mikkonen M; Alafuzoff I; Tapiola T; Soininen H; Miettinen R
    Neuroscience; 1999; 92(2):515-32. PubMed ID: 10408601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nerve growth factor receptor-immunoreactive neurons within the developing human cortex.
    Kordower JH; Mufson EJ
    J Comp Neurol; 1992 Sep; 323(1):25-41. PubMed ID: 1385492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
    van de Nes JA; Sandmann-Keil D; Braak H
    Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease.
    Morrison JH; Lewis DA; Campbell MJ; Huntley GW; Benson DL; Bouras C
    Brain Res; 1987 Jul; 416(2):331-6. PubMed ID: 3113670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus.
    Varga C; Härtig W; Grosche J; Keijser J; Luiten PG; Seeger J; Brauer K; Harkany T
    J Comp Neurol; 2003 Jun; 460(4):597-611. PubMed ID: 12717717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of somatostatin immunoreactivity in the human dentate gyrus.
    Amaral DG; Insausti R; Campbell MJ
    J Neurosci; 1988 Sep; 8(9):3306-16. PubMed ID: 2459324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptidergic neurons of subcortical white matter in aging and Alzheimer's brain.
    Ang LC; Shul DD
    Brain Res; 1995 Mar; 674(2):329-35. PubMed ID: 7540926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic proteins in Alzheimer's disease.
    Marksteiner J; Kaufmann WA; Gurka P; Humpel C
    J Mol Neurosci; 2002; 18(1-2):53-63. PubMed ID: 11931350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
    Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
    Neuroscience; 1994 Aug; 61(4):755-64. PubMed ID: 7838375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.
    Nakamura S; Vincent SR
    Brain Res; 1986 Apr; 370(1):11-20. PubMed ID: 2871890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.